Dr. John Magnani, PhD is the Director, Chief Scientific Officer and SVP Research of GlycoMimetics, Inc (Bethesda, MD).
He will be presenting a seminar on Tuesday, July 23, 2019 titled:
“Novel Mechanisms in Glycobiology are New Sources of Therapeutics Drugs now in Clinical Trials in Cancer and Inflammatory Disorders”.
This event is sponsored by:
The National Center for Functional Glycomics
Harvard Medical School Center for Glycoscience
Beth Israel Deaconess Medical Center